GGrantIndex
Sort

25,944 grants matching neurodegeneration

Worldwide Mapping of Air Pollution Exposure Patterns on Aging Brain Health

$662,575
Lauren E. Salminen · University Of Southern California · R01 · FY2022 · ES

Imaging Neurodegeneration in Multiple Sclerosis

$662,494
Peter A Calabresi · Johns Hopkins University · R01 · FY2024 · NS

Mesoscopic Biomarkers of Neurodegeneration and Inflammation with Diffusion MRI

$662,455
Els Fieremans · New York University School Of Medicine · R01 · FY2021 · NS

Modeling and Pathological Study of Sporadic Parkinson's Disease

$662,411
Huaibin Cai · National Institute On Aging · ZIA · FY2015 · AG

CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration

$662,384
Gregory A Cox · Jackson Laboratory · R01 · FY2020 · NS

CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration

$662,384
Gregory A Cox · Jackson Laboratory · R01 · FY2021 · NS

Mechanisms of pathology and neuronal hyperactivity in a memory circuit in Alzheimer's disease

$662,151
Edward S. Boyden · Massachusetts Institute Of Technology · R01 · FY2021 · AG

Urate as a Predictor of Parkinson's Disease Risk and Progression

$662,145
Alberto Ascherio · Harvard School Of Public Health · R01 · FY2010 · NS

Development of P2Y Receptor Ligands

$662,094
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Genetic analysis in families with neurological disease

$661,585
Andrew B Singleton · National Institute On Aging · Z01 · FY2008 · AG

Microbiome, Environment, and Parkinsons disease (MEP) PESTICIDE EXPOSURES AND THE GUT MICROBIOME IN PARKINSONS DISEASE

$661,570
Beate R Ritz · University Of California Los Angeles · R01 · FY2020 · ES

Role of mitochondrial GDAP1 in Alzheimer's disease

$661,566
Kirill Kiselyov · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AG

Analytical Tools for Light-Initiated Zn2+ Signaling in Neurodegenerative Disease

$661,537
Michael A. Johnson · University Of Kansas Lawrence · R01 · FY2025 · AG

Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration

$661,509
Gil Dan Rabinovici · University Of California, San Francisco · R01 · FY2014 · AG

Evaluating and Targeting RNA granules in neurodegenerative diseases

$661,492
Eugene Wei-Ming Yeo · University Of California, San Diego · R56 · FY2020 · AG

RNA-binding Factors Controlling Neurogenesis and Neurodegeneration

$661,436
Myriam Gorospe · National Institute On Aging · ZIA · FY2015 · AG

HIV-induced neuroinflammation associated with opiod abuse and tobacco smoke

$661,297
Thomas J Rogers · Temple Univ Of The Commonwealth · R01 · FY2019 · DA

Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use

$661,287
Kenneth W Witwer · Johns Hopkins University · R01 · FY2019 · DA

Identifying Drugs to Treat Age-Dependent Neurodegeneration

$661,262
Kim D. Finley · Expression Drug Designs, Llc · R44 · FY2011 · AG

Formation of Tau RNA Complexes disrupts tau function and drives tau neuropathology

$661,062
Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2025 · AG

Federated Deep Learning to Accelerate Alzheimer's Disease Research

$661,016
Paul M Thompson · University Of Southern California · R01 · FY2024 · AG

Risk Factors for Future Cognitive Decline and Alzheimer's Disease in Older African Americans

$660,978
Mark A Gluck · Rutgers The State Univ Of Nj Newark · R01 · FY2021 · AG

Insulin Resistance and Accelerated Cognitive Aging

$660,970
Natalie L Rasgon · Stanford University · R01 · FY2020 · AG

Role of midlife cardiovascular disease on Alzheimer’s Pathology and cerebrovascular reactivity in the young-old.

$660,940
Ann D. Cohen · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AG

Understanding the Contribution of Altered Cerebrovascular Function to the Pathology and Clinical Symptoms of Huntington Disease

$660,887
Herminia D Rosas · Massachusetts General Hospital · R01 · FY2025 · NS